Contact Us to Learn More: 1-877-516-1361

About the A16 Study

In people with Alzheimer’s, a protein called ‘tau’ builds up in the brain.

Up until recently, this protein could only be detected by viewing a small piece of the brain under a microscope after death.

But our researchers believe they may be able to detect tau using an investigational imaging dye (known as a ‘tracer’).

Our tracer has been developed to attach to tau in the brain and be highlighted during a brain scan.

As this can be done while the patient is alive, the tracer may help us diagnose Alzheimer’s faster and therefore begin treatment sooner.

To find out if we’re right, we must conduct a clinical research study to compare this new potential method of detecting tau (using a tracer), to the original method (examining the brain under a microscope after death), to check they match up.

And we need people with Alzheimer’s and people without Alzheimer’s to take part.